Mundipharma: Pain trials
The registry lists 33 Pain studies with Mundipharma as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 9Phase 2 6Phase 3 14Phase 4 4No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Analgesic Treatment for Cancer Pain in South East AsiaCompletedNCT02664987Results posted
- Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION)CompletedNCT01983111Phase 4Results posted
- Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer PainCompletedNCT01885182Phase 3Results posted
- OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) StudyCompletedNCT01643772Phase 1Results posted
- A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic PolyneuropathyCompletedNCT00944697Phase 2Results posted
- Trauma Acute Pain Treatment With Methoxyflurane Vaporized (PENTHROX®): Efficacy and Safety Study (MEDITA)CompletedNCT03585374Phase 3
- A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer PainCompletedNCT03176199Phase 4
- Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer PainCompletedNCT03176121Phase 4
- Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain PatientsStatus unknownNCT03155516Not applicable
- Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated PainCompletedNCT02452112Phase 2/3
- A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed MedicationCompletedNCT02446561Phase 1
- An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch AdhesionCompletedNCT02431624Phase 1
- Bioequivalence and Adhesion Comparison of Buprenorphine PatchesCompletedNCT02268422Phase 1
- A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation PatchesCompletedNCT02160067Phase 1
- A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong Painkillers in a Fasted and Fed State.CompletedNCT02133820Phase 1
- A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed MedicationCompletedNCT02089581Phase 1
- A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant PainCompletedNCT01971632Phase 3
- Targin for Non-cancer PainCompletedNCT01918098Phase 3
- Non-interventional Study Comparing Targiniq and Oxycodone/LaxativesCompletedNCT01812733
- Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese PatientCompletedNCT01482936Phase 1
- A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated PainCompletedNCT01439100Phase 3
- A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer TherapyCompletedNCT01438567Phase 3
- Norspan Efficacy and Safety Among Elderly SubjectsCompletedNCT01276431Phase 4
- OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)CompletedNCT01197261Phase 2
- Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant PainCompletedNCT01167699Phase 3
- Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant PainCompletedNCT01167127Phase 3
- Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain PatientsTerminatedNCT01014559Phase 3
- Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of PainCompletedNCT00992576Phase 2/3
- A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth PainTerminatedNCT00947466Phase 1/2
- A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer PainCompletedNCT00513656Phase 2
- Oxycodone-naloxone in Relieving Opioid-related ConstipationCompletedNCT00412152Phase 3
- Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related ConstipationCompletedNCT00412100Phase 3
- Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Osteoarthritic PainCompletedNCT00345787Phase 3